{"analyses":[{"ciLowerLimit":".59","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":".90","groupIds":["OG000"],"nonInferiorityType":"SUPERIORITY_OR_OTHER_LEGACY","paramType":"proportion","paramValue":"0.74"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"59","upperLimit":"90","value":"74"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"description":"Compliance is defined as taking at least 80% of the prescribed dose for one year.","dispersionType":"95% Confidence Interval","groups":[{"description":"Capecitabine 1000mg/day for one year\n\ncapecitabine\n\nadjuvant therapy","id":"OG000","title":"Capecitabine"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"within 365 days","title":"Compliance With Treatment .","type":"PRIMARY","unitOfMeasure":"percentage of participants"}